Browse > Article
http://dx.doi.org/10.4014/jmb.1610.10053

Potent Selective Inhibition of Monoamine Oxidase A by Alternariol Monomethyl Ether Isolated from Alternaria brassicae  

Lee, Hyun Woo (Department of Pharmacy and Research Institute of Life Pharmaceutical Sciences, Sunchon National University)
Kim, Yeon Ji (Department of Chemistry and Nano Science, Ewha Womans University)
Nam, Sang-Jip (Department of Chemistry and Nano Science, Ewha Womans University)
Kim, Hoon (Department of Pharmacy and Research Institute of Life Pharmaceutical Sciences, Sunchon National University)
Publication Information
Journal of Microbiology and Biotechnology / v.27, no.2, 2017 , pp. 316-320 More about this Journal
Abstract
Alternariol monomethyl ether (AME), a dibenzopyrone derivative, was isolated from Alternaria brassicae along with altertoxin II (ATX-II). The compounds were tested for the inhibitory activity of monoamine oxidase (MAO), which catalyzes neurotransmitting monoamines. AME was found to be a highly potent and selective inhibitor of human MAO-A with an $IC_{50}$ value of $1.71{\mu}M$; however, it was found to be ineffective for MAO-B inhibition. ATX-II was not effective for the inhibition of either MAO-A or MAO-B. The inhibition of MAO-A using AME was apparently instantaneous. MAO-A activity was almost completely recovered after the dilution of the inhibited enzyme with an excess amount of AME, suggesting AME is a reversible inhibitor. AME showed mixed inhibition for MAO-A in Lineweaver-Burk plots with a $K_i$ value of $0.34{\mu}M$. The findings of this study suggest that microbial metabolites and dibenzopyrone could be potent MAO inhibitors. In addition, AME could be a useful lead compound for developing reversible MAO-A inhibitors to treat depression, Parkinson's disease, and Alzheimer's disease.
Keywords
Alternariol monomethyl ether; monoamine oxidase; Alternaria brassicae; selective inhibitor; mixed inhibition;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Vina D, Serra S, Lamela M, Delogu G. 2012. Herbal natural products as a source of monoamine oxidase inhibitors: a review. Curr. Top. Med. Chem. 12: 2131-2144.   DOI
2 Lee HW, Jung WK, Kim HJ, Jeong YS, Nam SJ, Kang H, Kim H. 2015. Inhibition of monoamine oxidase by anithiactins from Streptomyces sp. J. Microbiol. Biotechnol. 25: 1425-1428.   DOI
3 Lee IK, Yun BS, Oh S, Kim YH, Lee MK, Yoo ID. 1999. 5-Methylmellein and nectriapyrone, two new monoamine oxidase inhibitors. Med. Sci. Res. 27: 463-465.
4 Marin S, Ramos AJ, Cano-Sancho G, Sanchis V. 2013. Mycotoxins: occurrence, toxicology, and exposure assessment. Food Chem. Toxicol. 60: 218-237.   DOI
5 Ostry V. 2008. Alternaria mycotoxins: an overview of chemical characterization, producers, toxicity, analysis and occurrence in foodstuffs. World Mycotoxin J. 1: 175-188.   DOI
6 Scott PM, Zhao W, Feng S, Lau BP. 2012. Alternaria toxins alternariol and alternariol monomethyl ether in grain foods in Canada. Mycotoxin Res. 28: 261-266.   DOI
7 Zhang SY, Li ZL, Bai J, Wang Y, Zhang LM, Wu X, Hua HM. 2012. A new perylenequinone from a halotolerant fungus, Alternaria sp. M6. Chin. J. Nat. Med. 10: 68-71.
8 Legoabe LJ, Petzer A, Petzer JP. 2012. Inhibition of monoamine oxidase by selected C6-substituted chromone derivatives. Eur. J. Med. Chem. 49: 343-353.   DOI
9 Schwarz C, Tiessen C, Kreutzer M, Stark T, Hofmann T, Marko D. 2012. Characterization of a genetoxic impact compound in Alternaria alternata infected rice as altertoxin II. Arch. Toxicol. 86: 1911-1925.   DOI
10 Lee HW, Ryu HW, Kang MG, Park D, Oh SR, Kim H. 2016. Potent selective monoamine oxidase B inhibition by maackiain, a pterocarpan from the roots of Sophora flavescens. Bioorg. Med. Chem. Lett. 26: 4714-4719   DOI
11 Petzer A, Harvey BH, Petzer JP. 2014. The interactions of azure B, a metabolite of methylene blue, with acetylcholinesterase and butyrylcholinesterase. Toxicol. Appl. Pharmacol. 274: 488-493.   DOI
12 Petzer A, Pienaar A, Petzer JP. 2013. The inhibition of monoamine oxidase by esomeprazole. Drug Res. (Stuttg.). 63: 462-467.   DOI
13 Yamada M, Yasuhara H. 2004. Clinical pharmacology of MAO inhibitors: safety and future. Neurotoxicology 25: 215-221.   DOI
14 Youdim MB, Edmondson D, Tipton KF. 2006. The therapeutic potential of monoamine oxidase inhibitors. Nat. Rev. Neurosci. 7: 295-309.   DOI
15 Mostert S, Petzer A, Petzer JP. 2015. Indanones as highpotency reversible inhibitors of monoamine oxidase. ChemMedChem. 10: 862-873.   DOI
16 Mattsson C, Svensson P, Sonesson C. 2014. A novel series of 6-substituted 3-(pyrrolidin-1-ylmethyl)chromen-2-ones as selective monoamine oxidase (MAO) A inhibitors. Eur. J. Med. Chem. 73: 177-186.   DOI
17 Abdelhafez OM, Amin KM, Ali HI, Abdalla MM, Batran RZ. 2012. Synthesis of new 7-oxycoumarin derivatives as potent and selective monoamine oxidase A inhibitors. J. Med. Chem. 55: 10424-10436.   DOI
18 Fowler JS, Logan J, Azzaro AJ, Fielding RM, Zhu W, Poshusta AK, et al. 2010. Reversible inhibitors of monoamine oxidase-A (RIMAs): robust, reversible inhibition of human brain MAOA by CX157. Neuropsychopharmacology 35: 623-631.   DOI
19 Gentili F, Pizzinat N, Ordener C, Marchal-Victorion S, Maurel A, Hofmann R, et al. 2006. 3-[5-(4,5-Dihydro-1Himidazol-2-yl)-furan-2-yl]phenylamine (amifuraline), a promising reversible and selective peripheral MAO-A inhibitor. J. Med. Chem. 49: 5578-5586.   DOI
20 Kim H, Sablin SO, Ramsay RR. 1997. Inhibition of monoamine oxidase A by ${\beta}$-carboline derivatives. Arch. Biochem. Biophys. 337: 137-142.   DOI
21 Berlin I, Zimmer R, Thiede HM, Payan C, Hergueta T, Robin L, Puech AJ. 1990. Comparison of the monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors moclobemide and toloxatone, and assessment of their effect on psychometric performance in healthy subjects. Br. J. Clin. Pharmacol. 30: 805-816.   DOI
22 Ramsay RR. 2012. Monoamine oxidases: the biochemistry of the proteins as targets in medicinal chemistry and drug discovery. Curr. Top. Med. Chem. 12: 2189-2209.   DOI
23 Dolle F, Valette H, Bramoulle Y, Guenther I, Fuseau C, Coulon C, et al. 2003. Synthesis and in vivo imaging properties of [11C]befloxatone: a novel highly potent positron emission tomography ligand for mono-amine oxidase-A. Bioorg. Med. Chem. Lett. 13: 1771-1775   DOI
24 Lotufo-Neto F, Trivedi M, Thase ME. 1999. Meta-analysis of the reversible inhibitors of monoamine oxidase type A moclobemide and brofaromine for the treatment of depression. Neuropsychopharmacology 20: 226-247.   DOI
25 Carradori S, D'Ascenzio M, Chimenti P, Secci D, Bolasco A. 2014. Selective MAO-B inhibitors: a lesson from natural products. Mol. Divers. 18: 219-243.   DOI
26 Mathew B, Suresh J, Mathew GE, Parasuraman R, Abdulla N. 2014. Plant secondary metabolites - potent inhibitors of monoamine oxidase isoforms. Cent. Nerv. Syst. Agents Med. Chem. 14: 28-33.   DOI
27 Orhan IE. 2016. Potential of natural products of herbal origin as monoamine oxidase inhibitors. Curr. Pharm. Des. 22: 268-276.